matched-adjusted comparison of liso-cel versus axi-cel for the second-line treatment of r/r lbcl
Published 1 year ago • 156 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
0:59
matching-adjusted indirect comparison of liso-cel vs axi-cel in the 2l treatment of r/r lbcl
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
2:19
primary analysis of the transform study: liso-cel vs soc as second-line treatment for r/r lbcl
-
2:46
transform: liso-cel versus standard of care as second-line therapy for r/r lbcl
-
1:21
approval of axi-cel in second-line for r/r lbcl & label update
-
1:36
real-world comparison of axi-cel and tisa-cel in r/r dlbcl
-
1:45
matched comparison of tisa-cel and axi-cel in r/r dlbcl
-
5:42
comparative effectiveness of liso-cel vs conventional 2l chemotherapy in r/r lbcl
-
24:35
how dna origami disrupts medicine and becomes the new cornerstone of nano robotics | dld 23
-
9:59
dr. kessler addresses questions about your hematology appointment
-
4:22
icount 3ts - 3 part hematology system 7 reasons for you to choose ! 70 tests per hour !
-
1:44
indirect comparison of brexu-cel versus soc in r/r mcl
-
4:01
matching-adjusted indirect comparison of elevate-tn versus sequoia
-
1:30
comparing efficacy outcomes of ide-cel versus conventional care in r/r myeloma
-
1:34
recent and upcoming data on axi-cel for patients with nhl
-
2:24
comparing allosct outcomes in secondary and de-novo acute lymphoblastic leukemia
-
4:11
comparing treatment options for treated secondary aml
-
8:57
outcomes of sct in t-all and t-lbl
-
1:35
cilta-cel vs ide-cel for r/r multiple myeloma: making the decision in clinical practice
-
2:41
an overview of the latest advances in hematology
-
1:48
the challenges of choosing the right target antigen in aml compared to all
-
4:11
allosct outcomes from younger matched unrelated donor versus older sibling donor for aml